These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 28831120)
41. Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis. Niu X; Zhang S; Shao C; Guo Z; Wu J; Tao J; Zheng K; Ye W; Cai G; Sun W; Li M PeerJ; 2023; 11():e15125. PubMed ID: 37065697 [TBL] [Abstract][Full Text] [Related]
42. Profiling of autoantibodies in IgA nephropathy, an integrative antibiomics approach. Sigdel TK; Woo SH; Dai H; Khatri P; Li L; Myers B; Sarwal MM; Lafayette RA Clin J Am Soc Nephrol; 2011 Dec; 6(12):2775-84. PubMed ID: 22157707 [TBL] [Abstract][Full Text] [Related]
43. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression. Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236 [TBL] [Abstract][Full Text] [Related]
44. Functional networks of aging markers in the glomeruli of IgA nephropathy: a new therapeutic opportunity. Jiang H; Liang L; Qin J; Lu Y; Li B; Wang Y; Lin C; Zhou Q; Feng S; Yip SH; Xu F; Lai EY; Wang J; Chen J Oncotarget; 2016 Jun; 7(23):33616-26. PubMed ID: 27127888 [TBL] [Abstract][Full Text] [Related]
45. The therapeutic effect of dendritic cells expressing indoleamine 2,3-dioxygenase (IDO) on an IgA nephropathy mouse model. Liu K; Yang Y; Chen Y; Li S; Gong Y; Liang Y Int Urol Nephrol; 2020 Feb; 52(2):399-407. PubMed ID: 31894556 [TBL] [Abstract][Full Text] [Related]
46. Comparative proteomic analysis of renal proteins from IgA nephropathy model mice and control mice. Miyakawa R; Sato A; Matsuda Y; Saito A; Abe F; Matsumura H; Odaka M; Suzuki T; Dohmae N; Komatsuda A; Takahashi N; Wakui H Clin Exp Nephrol; 2020 Aug; 24(8):666-679. PubMed ID: 32436031 [TBL] [Abstract][Full Text] [Related]
47. Proteomic approach for identification of IgA nephropathy-related biomarkers in urine. Prikryl P; Vojtova L; Maixnerova D; Vokurka M; Neprasova M; Zima T; Tesar V Physiol Res; 2017 Sep; 66(4):621-632. PubMed ID: 28406696 [TBL] [Abstract][Full Text] [Related]
48. Expression of P311, a transforming growth factor beta latency-associated protein-binding protein, in human kidneys with IgA nephropathy. Wang F; Xie X; Fan J; Wang L; Guo D; Yang L; Ma X; Zhang L; Li Z Int Urol Nephrol; 2010 Sep; 42(3):811-9. PubMed ID: 19946746 [TBL] [Abstract][Full Text] [Related]
49. Renal expression of trefoil factor 3 mRNA in association with tubulointerstitial fibrosis in IgA nephropathy. Tanaka K; Sugiyama H; Yamanari T; Mise K; Morinaga H; Kitagawa M; Onishi A; Ogawa-Akiyama A; Tanabe K; Eguchi J; Ohmoto Y; Shikata K; Wada J Nephrology (Carlton); 2018 Sep; 23(9):855-862. PubMed ID: 29987860 [TBL] [Abstract][Full Text] [Related]
50. Translocation of dendrin to the podocyte nucleus in acute glomerular injury in patients with IgA nephropathy. Kodama F; Asanuma K; Takagi M; Hidaka T; Asanuma E; Fukuda H; Seki T; Takeda Y; Hosoe-Nagai Y; Asao R; Horikoshi S; Tomino Y Nephrol Dial Transplant; 2013 Jul; 28(7):1762-72. PubMed ID: 23143340 [TBL] [Abstract][Full Text] [Related]
51. Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathy. Mao J; Zhang Y; Du L; Dai Y; Yang C; Liang L Pediatr Nephrol; 2006 Nov; 21(11):1666-75. PubMed ID: 16941146 [TBL] [Abstract][Full Text] [Related]
52. Urinary mi-106a for the diagnosis of IgA nephropathy: Liquid biopsy for kidney disease. Szeto CC; Ng JK; Fung WW; Chan GC; Luk CC; Lai KB; Wang G; Chow KM; Mac-Moune Lai F Clin Chim Acta; 2022 May; 530():81-86. PubMed ID: 35278407 [TBL] [Abstract][Full Text] [Related]
54. Use of liquid chromatography-tandem mass spectrometry to perform urinary proteomic analysis of children with IgA nephropathy and Henoch-Schönlein purpura nephritis. Fang X; Lu M; Xia Z; Gao C; Cao Y; Wang R; Wang M; Wu H J Proteomics; 2021 Jan; 230():103979. PubMed ID: 32932007 [TBL] [Abstract][Full Text] [Related]
55. The increased miRNA-150-5p expression of the tonsil tissue in patients with IgA nephropathy may be related to the pathogenesis of disease. Xu Y; He Y; Hu H; Xu R; Liao Y; Dong X; Song H; Chen X; Chen J Int Immunopharmacol; 2021 Nov; 100():108124. PubMed ID: 34600394 [TBL] [Abstract][Full Text] [Related]
56. A polymorphism of interleukin-22 receptor alpha-1 is associated with the development of childhood IgA nephropathy. Suh JS; Cho SH; Chung JH; Moon A; Park YK; Cho BS J Interferon Cytokine Res; 2013 Oct; 33(10):571-7. PubMed ID: 23659670 [TBL] [Abstract][Full Text] [Related]
57. Comprehensive metabolomic profiling in early IgA nephropathy patients reveals urine glycine as a prognostic biomarker. Park S; Lee J; Yang SH; Lee H; Kim JY; Park M; Kim KH; Moon JJ; Cho S; Lee S; Kim Y; Lee H; Lee JP; Jeong CW; Kwak C; Joo KW; Lim CS; Kim YS; Hwang GS; Kim DK J Cell Mol Med; 2021 Jun; 25(11):5177-5190. PubMed ID: 33939273 [TBL] [Abstract][Full Text] [Related]
58. Role of let-7b in the regulation of N-acetylgalactosaminyltransferase 2 in IgA nephropathy. Serino G; Sallustio F; Curci C; Cox SN; Pesce F; De Palma G; Schena FP Nephrol Dial Transplant; 2015 Jul; 30(7):1132-9. PubMed ID: 25744272 [TBL] [Abstract][Full Text] [Related]
59. Apoptosis inhibitor of macrophage as a biomarker for disease activity in Japanese children with IgA nephropathy and Henoch-Schönlein purpura nephritis. Irabu H; Shimizu M; Kaneko S; Inoue N; Mizuta M; Tasaki Y; Ohta K; Yachie A; Wada T Pediatr Res; 2021 Feb; 89(3):667-672. PubMed ID: 32408340 [TBL] [Abstract][Full Text] [Related]
60. Noninvasive Urinary Monitoring of Progression in IgA Nephropathy. Yang JYC; Sarwal RD; Fervenza FC; Sarwal MM; Lafayette RA Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510053 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]